Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial-Reference-Cited by-同舟云学术

Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial

Published:2022-12 Issue: Volume:86 Page:104322
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Chandiwana Nomathemba^ORCID,Kruger Chelsea,Johnstone Hilary,Chughlay Mohamed Farouk,Ju Chung,Kim Byungsu,Dineka Yengiwe,Arbe-Barnes Sarah,Miller Robert,Owen Andrew,Hill Andrew,Windgassen Daniel,Abla Nada,Marrast Anne Claire,Duparc Stephan,Francois Venter Willem Daniel

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference45 articles.

1. Coronavirus resource center,2021

2. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study;Augustin;Lancet Reg Health Eur,2021

3. Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households;Carrat;Antivir Ther,2012

4. Therapy for early COVID-19: a critical need;Kim;JAMA,2020

5. Editorial: current status of oral antiviral drug treatments for SARS-CoV-2 infection in non-hospitalized patients;Parums;Med Sci Monit,2022

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the potential of signature-based drug repurposing for anticancer drug discovery;Archives of Biochemistry and Biophysics;2024-11

2. Predicting Clinical Outcomes of SARS‐CoV‐2 Drug Efficacy with a High‐Throughput Human Airway Microphysiological System;Advanced Biology;2024-08-09

3. PBPK‐led assessment of antimalarial drugs as candidates for Covid‐19: Simulating concentrations at the site of action to inform repurposing strategies;Clinical and Translational Science;2024-07

4. Assessment of the efficacy and safety of favipiravir in patients with SARS-CoV-2 infection in United Arab Emirates: A single-center study;PHARM PRACT-GRANADA;2024

5. The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis;Journal of Antimicrobial Chemotherapy;2024-02-22